1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Staphylococcus Aureus Endocarditis: new trials by email Literature Review of Staphylococcus Aureus Endocarditis trials Research Report on Staphylococcus Aureus Endocarditis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia Ertapenem, Placebo - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia | Phase 2 | Recruiting | Todd C. Lee MD MPH FIDSA | 60 | 2024-05-20 | 2026-11-02 |
| Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia CF-301, Placebo - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis | Phase 2 | Completed | ContraFect | 121 | 2017-05-23 | 2021-10-08 |
Bacteremia (2) · Staphylococcal Infections (2)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Sepsis (2) · Systemic Inflammatory Response Syndrome (2)
ContraFect (1) · Todd C. Lee MD MPH FIDSA (1)
Belgium (1) · Bulgaria (1) · Canada (1) · Chile (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Guatemala (1) · Israel (1) · Italy (1) · Russia (1) · Spain (1) · United Kingdom (1) · United States (1)
Emily G McDonald, MD MSc (1) · Matthew P Cheng, MD (1) · Todd C Lee, MD MPH FIDSA (1)